| Basic Medical Information |
| Common Brand Name |
| Micardis |
Avapro |
| Drug Class |
| Angiotensin-receptor Blockers |
Angiotensin-receptor Blockers |
| Legal Status |
| S4 (au), Pom (uk), Rx-only (u.s.) |
S4 (au), Pom (uk), Rx-only (us) |
| Possible Side Effects |
| Dizziness, Lightheadedness, Blurred Vision, Back Pain, Fainting, Impotence, Muscle Pain, Nausea, Vomiting, Skin Rashes, Difficulty Breathing |
Dizziness, Lightheadedness, Or Upset Stomach, Fainting, Irregular Heartbeat, Skin Rashes, Swelling, Difficulty Breathing |
| Precautions & Contraindications |
| Heart Disease, Cirrhosis, Gallstones, Kidney Disease, Allergies, Pregnant, Breastfeeding, Dialysis |
Heart Disease, Kidney Disease, Allergies, Pregnant, Breastfeeding, Dialysis |
| Excretion |
| Fecal |
Renal, Fecal |
|
| Dosage, Usage and Forms |
| Route of Administration |
| Oral |
Oral |
| Dosage |
| 40 Mg |
150 Mg |
| Maximum daily dose |
| 80 mg |
300 mg |
| Forms |
| Tablet |
Tablet |
| Tablet Formulations |
| 20 Mg, 40 Mg, 80 Mg |
75 Mg, 150 Mg, 300 Mg |
| Chemical Data |
| Molecular mass (g/mol) |
| 514.62 g/mol |
428.53 g/mol |
| Half Life (hours) |
| 24 |
15 |
| Chemicals |
| Carbon, Hydrogen, Nitrogen, Oxygen |
Carbon, Hydrogen, Nitrogen, Oxygen |
| Formula |
| C33h30n4o2 |
C25h28n6o |
| Melting Point (C) |
| 262 C |
181 C |
| Phase (solid/liquid) |
| Solid |
Solid |